Introduction Two unsung hero hormones—Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) have emerged as targets for groundbreaking therapies that reshape the way we approach diabetes treatment and weight loss management. GLP-1 and GIP are secreted in response to food intake, and are insulinotropic (have the ability to stimulate the release of insulin, orchestrating the […]
Introduction Two unsung hero hormones—Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) have emerged as targets for groundbreaking therapies that reshape the way we approach diabetes treatment and weight loss
Radiopharmaceutical Drugs Radiopharmaceutical therapy (RPT), also known as radioligand therapy (RLT), is emerging as a novel and promising approach to combat cancer. This innovative therapeutic method harnesses the potency of radioactive substances, termed radioligands, to
With the discovery of DNA polymerase in 1956, an enzyme that replicates DNA, a new world of science was opened. The next big discovery in 1970 was Reverse Transcriptase (RT) that uses RNA as a template to synthesize DNA. Later, DNA …
